In the BioHarmony Drug Report Database

"Preview" Icon

Hydrocortisone butyrate

Locoid, Locoid Lipocream, Alkindi, Efmody, Plenadren (hydrocortisone butyrate) is a small molecule pharmaceutical. Hydrocortisone butyrate was first approved as Locoid on 1982-03-31. It is used to treat adrenal insufficiency, congenital adrenal hyperplasia, contact dermatitis, facial dermatoses, and foot dermatoses amongst others in the USA. It has been approved in Europe to treat adrenal insufficiency and congenital adrenal hyperplasia. Hydrocortisone butyrate’s patent is valid until 2026-12-19 (FDA).

 

Trade Name

 

Alkindi, Efmody, Plenadren
 

Common Name

 

hydrocortisone butyrate
 

ChEMBL ID

 

CHEMBL1683
 

Indication

 

adrenal insufficiency, congenital adrenal hyperplasia, contact dermatitis, facial dermatoses, foot dermatoses, hand dermatoses, hemorrhoids, inflammation, leg dermatoses, pruritus ani, rheumatic diseases, scalp dermatoses, shock, status asthmaticus, ulcerative colitis
 

Drug Class

 

Cortisone derivatives

Image (chem structure or protein)

Hydrocortisone butyrate structure rendering